Ioanna Dimopoulou to Critical Illness
This is a "connection" page, showing publications Ioanna Dimopoulou has written about Critical Illness.
Connection Strength
0.433
-
Covid-19 and Growth Hormone/Insulin-Like Growth Factor 1: Study in Critically and Non-Critically Ill Patients. Front Endocrinol (Lausanne). 2021; 12:644055.
Score: 0.167
-
Serial changes in adiponectin and resistin in critically ill patients with sepsis: associations with sepsis phase, severity, and circulating cytokine levels. J Crit Care. 2012 Aug; 27(4):400-9.
Score: 0.090
-
Increased Glucocorticoid Receptor Alpha Expression and Signaling in Critically Ill Coronavirus Disease 2019 Patients. Crit Care Med. 2021 12 01; 49(12):2131-2136.
Score: 0.043
-
Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19. In Vivo. 2021 Mar-Apr; 35(2):1295-1298.
Score: 0.041
-
Glycemia, Beta-Cell Function and Sensitivity to Insulin in Mildly to Critically Ill Covid-19 Patients. Medicina (Kaunas). 2021 Jan 14; 57(1).
Score: 0.041
-
Microdialysis-Assessed Adipose Tissue Metabolism in Critically Ill Patients. Recent Pat Endocr Metab Immune Drug Discov. 2017; 11(1):32-38.
Score: 0.031
-
ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients. Cells. 2021 Jan 19; 10(1).
Score: 0.010
-
A novel ratio of CD8+:B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcome. Virology. 2021 04; 556:79-86.
Score: 0.010